ALSO IN THIS MONTH'S ISSUE
Trump Threatens Rx Industry With Executive Orders
As Trump’s one-month deadline for a deal with PhRMA ticks away, nervous pharmaceutical executives are equally dismissive and anxious about the next actions of an often-impulsive president.
The Politicizing Of Healthcare Vs. Principled Public Health Policy
Politics must not drive population health. How do we safeguard against October surprises and ensure that announcements on drug and vaccine developments and approvals are driven by science and not politics?
Trends In Bioprocessing CDMO Selection
Which CDMO characteristics do experienced outsourcers value the most when choosing a CDMO for biologic API production? Data from the past three iterations of ISR’s Bioprocessing Market Trends and Outsourcing Dynamics show the top selection metrics remain cosnsistent despite some shifts in ranks over the years. Learn which attributes to focus on as a sponsor or CDMO.
Demystifying AI In Pharma
AI is less about the tool than what it can do. Instead of thinking about AI as a smart machine or some theoretical statistical algorithm, think of it as a framework consisting of five other words starting with “A”: automated, assistive, analytical, accelerated, and augmented.
COVID-19's Effect On Life Science Litigation
For life sciences companies trying to navigate pre-COVID-19 obligations in this new post-coronavirus world, there are contractual provisions, relevant legal doctrines, and realities of the judicial system that warrant careful consideration.
BEYOND THE PRINTED PAGE
Who Chooses the Choosers? — Ethical Considerations For Distribution Of COVID-19 Vaccines
Life Science Leader editorial advisory board member Kenneth Moch, co-founder or CEO of six life science companies, discusses ethical considerations regarding the distribution and delivery of an approved COVID-19 vaccine within a given country.
The Benefit Of Having A Highly Engaged Editorial Advisory Board
Newest Life Science Leader editorial advisory board member, Pamela Reilly Contag, Ph.D., cofounder and CEO of BioEclipse, provides a comprehensive response to recent “Ask The Board” question, “What has been the greatest biopharma business related insight you have gained from continued operation during the first half of this year?”
Lawrence Blatt: Biopharma Entrepreneur And Professional Musician
Lawrence Blatt, Ph.D., cofounder and CEO of Aligos Therapeutics, his latest biopharma entrepreneurial venture, provides insight into the music industry, as he happens to also be a professional musician.
Understanding and Implementing the EU Regulation for Initiating and Conducting Clinical Trials
August 17 - 17, 2020
1pm-2:30pm EDT, Online Training Duration: 90-Minutes
Price: $299 - Includes Bonus Handouts!
Aseptic Process Validation: Top-Tips for Compliance and Success
August 20 - 20, 2020
1pm-2:30pm EDT, Online Training Price: $299 - Includes Bonus Handouts!
15th International Conference on Agriculture & Horticulture
August 24 - 25, 2020
29th World Conference on Food & Beverages
August 24 - 25, 2020
Preparing for Changes to ICH GCP E6(R3) and ICH E8(R1) – Readying for Risk Mitigation
August 25 - 25, 2020
1pm-2:00pm EDT, Online Training Duration: 60-Minutes
Price: $199 - Includes Bonus Handouts!